» Articles » PMID: 37138785

Data-Resource Profile: United Kingdom Optimum Patient Care Research Database

Overview
Journal Pragmat Obs Res
Publisher Dove Medical Press
Specialty General Medicine
Date 2023 May 4
PMID 37138785
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Electronic medical records (EMRs) maintained in primary care in the UK and collected and stored in EMR databases offer a world-leading resource for observational clinical research. We aimed to profile one such database: the Optimum Patient Care Research Database (OPCRD).

Methods And Participants: The OPCRD, incepted in 2010, is a growing primary care EMR database collecting data from 992 general practices within the UK. It covers over 16.6 million patients across all four countries within the UK, and is broadly representative of the UK population in terms of age, sex, ethnicity and socio-economic status. Patients have a mean duration of 11.7 years' follow-up (SD 17.50), with a majority having key summary data from birth to last data entry. Data for the OPCRD are collected incrementally monthly and extracted from all of the major clinical software systems used within the UK and across all four coding systems (Read version 2, Read CTV3, SNOMED DM+D and SNOMED CT codes). Via quality-improvement programmes provided to GP surgeries, the OPCRD also includes patient-reported outcomes from a range of disease-specific validated questionnaires, with over 66,000 patient responses on asthma, COPD, and COVID-19. Further, bespoke data collection is possible by working with GPs to collect new research via patient-reported questionnaires.

Findings To Date: The OPCRD has contributed to over 96 peer-reviewed research publications since its inception encompassing a broad range of medical conditions, including COVID-19.

Conclusion: The OPCRD represents a unique resource with great potential to support epidemiological research, from retrospective observational studies through to embedded cluster-randomised trials. Advantages of the OPCRD over other EMR databases are its large size, UK-wide geographical coverage, the availability of up-to-date patient data from all major GP software systems, and the unique collection of patient-reported information on respiratory health.

Citing Articles

Incidence and survival of interstitial lung diseases in the UK in 2010-2019.

Gonnelli F, Eleangovan N, Smith U, Heatley H, Navarantam V, Corte T ERJ Open Res. 2025; 11(2).

PMID: 40040895 PMC: 11874205. DOI: 10.1183/23120541.00823-2024.


A machine learning algorithm for the detection of paroxysmal nocturnal haemoglobinuria (PNH) in UK primary care electronic health records.

Worker A, Mahon H, Sams J, Boardman-Pretty F, Marchini E, Dubis R Orphanet J Rare Dis. 2024; 19(1):378.

PMID: 39396996 PMC: 11479535. DOI: 10.1186/s13023-024-03406-4.


Exacerbation history and blood eosinophil count prior to diagnosis of COPD and risk of subsequent exacerbations.

Halpin D, Healey H, Skinner D, Carter V, Pullen R, Price D Eur Respir J. 2024; 64(4).

PMID: 39147410 PMC: 11447287. DOI: 10.1183/13993003.02240-2023.


Budesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population: Real-World Use and Early Medication Success.

Mullerova H, Chan J, Heatley H, Carter V, Townend J, Skinner D Int J Chron Obstruct Pulmon Dis. 2024; 19:1153-1166.

PMID: 38813078 PMC: 11134059. DOI: 10.2147/COPD.S452624.


Big Data Research on Severe Asthma.

Kim S, Kim Y Tuberc Respir Dis (Seoul). 2024; 87(3):213-220.

PMID: 38443148 PMC: 11222096. DOI: 10.4046/trd.2023.0186.


References
1.
Davey P, Kirby M . Cardiovascular risk profiles of GnRH agonists and antagonists: real-world analysis from UK general practice. World J Urol. 2020; 39(2):307-315. PMC: 7910366. DOI: 10.1007/s00345-020-03433-3. View

2.
Benson T . Why general practitioners use computers and hospital doctors do not--Part 1: incentives. BMJ. 2002; 325(7372):1086-9. PMC: 131190. DOI: 10.1136/bmj.325.7372.1086. View

3.
Smith J, Musgrave S, Payerne E, Noble M, Sims E, Clark A . At-risk registers integrated into primary care to stop asthma crises in the UK (ARRISA-UK): study protocol for a pragmatic, cluster randomised trial with nested health economic and process evaluations. Trials. 2018; 19(1):466. PMC: 6116486. DOI: 10.1186/s13063-018-2816-z. View

4.
Stanley B, Davis A, Jones R, Julious S, Ryan D, Jackson D . Characteristics of patients in platform C19, a COVID-19 research database combining primary care electronic health record and patient reported information. PLoS One. 2021; 16(10):e0258689. PMC: 8525750. DOI: 10.1371/journal.pone.0258689. View

5.
Price D, Jones R, Pfister P, Cao H, Carter V, Kemppinen A . Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic.... Pragmat Obs Res. 2021; 12:25-35. PMC: 8163732. DOI: 10.2147/POR.S302809. View